secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncotelic Therapeutics, Inc. (OTLC)
CIK:        0000908259
Form:       8-K
Filed at:   2026-01-06T23:59:59+00:00
Accession:  0001493152-26-000619
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncotelic lowers market cap milestone for Jefferson Capital from $100M to $45M
------------------------------------------------------------------------------

- Amendment reduces first milestone threshold in independent contractor agreement from $100M to $45M market cap.
- Contractor Jefferson Capital Ventures eligible to earn restricted stock upon achieving new $45M milestone.
- Amendment aims to facilitate progress on equity line with Mast Hills, AGP financing, and uplisting.
- No other terms of the milestone or ICA were changed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/908259/000149315226000619/0001493152-26-000619-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/908259/000149315226000619/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-000619

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer